Case Report: Mycosis fungoides as an exclusive manifestation of common variable immunodeficiency in a family with a NFKB2 gene mutation

Common variable immunodeficiency disorders (CVIDs), which are primary immunodeficiencies characterized by the failure of primary antibody production, typically present with recurrent bacterial infections, decreased antibody levels, autoimmune features, and rare atypical manifestations that can complicate diagnosis and management. Although most cases are sporadic, approximately 10% of the patients may have a family history of immunodeficiency. Genetic causes involving genes related to B-cell development and survival have been identified in only a small percentage of cases.We present the case of a family with two brothers who presented with mycosis fungoides as an exclusive symptom of a common variable immunodeficiency disorder (CVID). Whole-exome sequencing of the index patient revealed a pathogenic variant of the NFKB2 gene. Based on this diagnosis and re-evaluation of other family members, the father and brother were diagnosed with this rare immune and preneoplastic syndrome. All CVID-affected family members presented with mycosis fungoides as their only symptom, which is, to the best of our knowledge, the first case to be reported.This case highlights the importance of high-throughput sequencing techniques for the proper diagnosis and treatment of hereditary hematological disorders.

[1]  B. Grimbacher,et al.  Common Variable Immunodeficiency: More Pathways than Roads to Rome. , 2022, Annual review of pathology.

[2]  M. Bonder,et al.  Single-cell Atlas of common variable immunodeficiency shows germinal center-associated epigenetic dysregulation in B-cell responses , 2022, Nature Communications.

[3]  R. Krüger,et al.  A Pathogenic Missense Variant in NFKB1 Causes Common Variable Immunodeficiency Due to Detrimental Protein Damage , 2021, Frontiers in Immunology.

[4]  R. Willemze,et al.  Incidence of mycosis fungoides and Sézary syndrome in the Netherlands between 2000 and 2020 , 2021, The British journal of dermatology.

[5]  C. Lebbé,et al.  Epidemiology of Cutaneous T-Cell Lymphomas: A Systematic Review and Meta-Analysis of 16,953 Patients , 2020, Cancers.

[6]  R. Ameratunga,et al.  Defining Common Variable Immunodeficiency Disorders in 2020. , 2020, Immunology and allergy clinics of North America.

[7]  Z. Zeng,et al.  Intestinal Flora and Disease Mutually Shape the Regional Immune System in the Intestinal Tract , 2020, Frontiers in Immunology.

[8]  C. Cunningham-Rundles,et al.  Lymphoproliferative Disease in CVID: a Report of Types and Frequencies from a US Patient Registry , 2020, Journal of Clinical Immunology.

[9]  N. Rubin,et al.  Mycosis fungoides: developments in incidence, treatment and survival , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

[10]  C. Cunningham-Rundles,et al.  Current Genetic Landscape in Common Variable Immune Deficiency. , 2020, Blood.

[11]  A. Maguire,et al.  Early-stage Mycosis Fungoides: Epidemiology and Prognosis , 2020, Acta dermato-venereologica.

[12]  C. Klemann,et al.  Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in NFKB2 , 2019, Front. Immunol..

[13]  R. Płoski,et al.  A Novel Monoallelic Nonsense Mutation in the NFKB2 Gene Does Not Cause a Clinical Manifestation , 2019, Front. Genet..

[14]  E. López-Granados,et al.  Epigenetic Deregulation in Human Primary Immunodeficiencies. , 2019, Trends in immunology.

[15]  Crina Samarghitean,et al.  Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans , 2018, The Journal of allergy and clinical immunology.

[16]  Anne-Kathrin Kienzler,et al.  The role of genomics in common variable immunodeficiency disorders , 2017, Clinical and experimental immunology.

[17]  A. Skytthe,et al.  Investigating heredity in cutaneous T-cell lymphoma in a unique cohort of Danish twins , 2017, Blood Cancer Journal.

[18]  B. Lambrecht,et al.  Genes associated with common variable immunodeficiency: one diagnosis to rule them all? , 2016, Journal of Medical Genetics.

[19]  J. Byrd,et al.  DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia , 2016, Nature Genetics.

[20]  Ronald P. Schuyler,et al.  Whole-genome fingerprint of the DNA methylome during human B cell differentiation , 2015, Nature Genetics.

[21]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[22]  J. Drouin,et al.  Mutations in NFKB2 and potential genetic heterogeneity in patients with DAVID syndrome, having variable endocrine and immune deficiencies , 2014, BMC Medical Genetics.

[23]  Emily M. Coonrod,et al.  Germline mutations in NFKB2 implicate the noncanonical NF-κB pathway in the pathogenesis of common variable immunodeficiency. , 2013, American journal of human genetics.

[24]  D. Gillis,et al.  New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin , 2013, Clinical and experimental immunology.

[25]  C. Cunningham-Rundles,et al.  Morbidity and mortality in common variable immune deficiency over 4 decades. , 2012, Blood.

[26]  C. Cunningham-Rundles,et al.  Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions , 2009, British journal of haematology.

[27]  Shigeaki Nonoyama,et al.  Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. , 2007, The Journal of allergy and clinical immunology.

[28]  Nicola Pimpinelli,et al.  WHO-EORTC classification for cutaneous lymphomas. , 2005, Blood.

[29]  P. Itin,et al.  Familial Cutaneous Mycosis fungoides: Successful Treatment with a Combination of Gemcitabine and Alemtuzumab , 2004, Dermatology.

[30]  M. Lapidoth,et al.  Mycosis fungoides: HLA class II associations among Ashkenazi and non‐Ashkenazi Jewish patients , 2001, The British journal of dermatology.

[31]  K. Sharquie,et al.  Mycosis fungoides in identical twins. , 2001, Journal of the American Academy of Dermatology.

[32]  E. Harhaj,et al.  NF-κB-Inducing Kinase Regulates the Processing of NF-κB2 p100 , 2001 .

[33]  L. Notarangelo,et al.  Diagnostic Criteria for Primary Immunodeficiencies , 1999 .

[34]  R. Kurzrock,et al.  Transformation of mycosis fungoides/Sezary syndrome: clinical characteristics and prognosis. , 1998, Blood.

[35]  I. Vořechovský,et al.  Family and linkage study of selective IgA deficiency and common variable immunodeficiency. , 1995, Clinical immunology and immunopathology.

[36]  H. Kerl,et al.  Clinicopathologic and Immunologic Features Associated With Transformation of Mycosis Fungoides to Large‐Cell Lymphoma , 1992, The American journal of surgical pathology.

[37]  R S Chaganti,et al.  Non‐hodgkin lymphoma in common variable immunodeficiency , 1991, American journal of hematology.

[38]  L. King,et al.  Clinical features associated with transformation of cerebriform T‐cell lymphoma to a large cell process , 1990, Hematological oncology.

[39]  J. Greer,et al.  Transformation of cutaneous T cell lymphoma to large cell lymphoma. A clinicopathologic and immunologic study. , 1988, The American journal of pathology.

[40]  W. Shelley Familial mycosis fungoides revisited. , 1980, Archives of dermatology.

[41]  M. Sandbank,et al.  Mycosis fungoides of prolonged duration in siblings. , 1968, Archives of dermatology.

[42]  O. J. Cameron MYCOSIS FUNGOIDES IN MOTHER AND IN DAUGHTER , 1933 .

[43]  C. Cunningham-Rundles,et al.  International Consensus Document (ICON): Common Variable Immunodeficiency Disorders. , 2016, The journal of allergy and clinical immunology. In practice.